Many Americans with diabetes and chronic conditions struggle to pay for their medications, often even going into debt to pay for insulin or other vital prescriptions. With no end in sight to rising drug costs for both patients and payers, what can be done to relieve the financial burden of type 2 diabetes and other chronic conditions?
Date: Oct 13, 2022
Speakers:
+ Ron Harrison (VP of Business Development, Mark Cuban CostPlus Drug Company)
+ Dr. Sharon Jhawar (Chief Pharmacy Officer, SCAN Health)
+ Dr. William Shrank (Senior Advisor, Humana)
+ Dr. Chantell Sell (National Clinical Pharmacy Lead, Willis Towers Watson)